New ultrasound technique could sharpen ovarian cancer detection

NCT ID NCT07280312

Recruiting now Diagnosis Sponsor: Mayo Clinic Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new ultrasound technique called microvessel imaging (UMI) to see if it can better detect small blood vessels in ovarian lesions, which may indicate cancer. Forty women scheduled for ovarian surgery will receive both standard and UMI ultrasounds. Doctors will compare the imaging results with the final surgical findings to see if UMI improves accuracy.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Ultrasound microvessel imaging (UMI) and transvaginal ultrasound
What this could lead to: If successful, this could lead to a more accurate, non-invasive way to assess ovarian lesions, helping doctors decide who needs surgery.
What could go wrong: This is a small, early-stage study (40 people) testing a new imaging technique. It may not prove better than current methods, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADNEXAL LESION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

epidermal appendage tumor female reproductive system neoplasm ovarian cancer ovarian carcinoma ovarian cyst ovarian neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ADNEXAL LESION FEMALE REPRODUCTIVE SYSTEM ADNEXAL NEOPLASM FEMALE REPRODUCTIVE SYSTEM NEOPLASM OVARIAN CARCINOMA OVARIAN LESION OVARIAN NEOPLASMS

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

Mayo Clinic in Rochester
RECRUITING

Rochester, Minnesota, 55905, United States

Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.